Skip to main content
. Author manuscript; available in PMC: 2021 Feb 12.
Published in final edited form as: Asia Pac J Ophthalmol (Phila). 2018 May 29;7(3):136–144. doi: 10.22608/APO.201850

FIGURE 1.

FIGURE 1.

Late recurrence of active ROP after anti-VEGF injections. A 15-month-old male (GA 24 2/7 weeks) received a total of 3 intravitreal bevacizumab injections each in both eyes at an outside institution. Most recent injections were at 12 months chronological age. Examination was notable for zone II stage 3 ROP without plus disease in the right (A, C) and left (B, D) eyes. Given the patient’s age and history of multiple injections with late recurrence, laser photocoagulation was administered to both eyes (E, F).